| Class 2 Device Recall Microphthalmia Transcription Factor | |
Date Initiated by Firm | July 14, 2017 |
Create Date | September 12, 2017 |
Recall Status1 |
Terminated 3 on August 02, 2024 |
Recall Number | Z-3122-2017 |
Recall Event ID |
78055 |
Product Classification |
Immunohistochemistry reagents and kits - Product Code NJT
|
Product | Cell Marque, Microphthalmia Transcription Factor (MiTF) (C5/D5 Mab.), 7 mL, REF PA0803, IVD,
The antibody is intended for in vitro diagnostic (IVD) use. The Microphthalmia Transcription Factor (MiTF) (C5/D5) antibody is intended for qualified laboratories to qualitatively identify by light microscopy the presence of associated antigens in sections of formalin-fixed, paraffin-embedded tissue sections using IHC test methods. |
Code Information |
Product Code PA0803, Lot No. 46524, Exp. Date 06/25/2019 |
Recalling Firm/ Manufacturer |
Leica Biosystems Richmond Inc. 5205 Route 12 Richmond IL 60071
|
For Additional Information Contact | 815-678-2000 |
Manufacturer Reason for Recall | A delay in transit may have contributed to nonconformity as the product was stored outside of defined shipping and handling temperature requirements. |
FDA Determined Cause 2 | Storage |
Action | Advance Cancer Diagnostics sent an Urgent Medical Device Recall letter dated July 12, 2017, to all affected customers. The letter identified the product, the problem and the action to be taken by the customer. Customers were instructed to identify any affected products, discard them, and complete and return the Medical Device Acknowledgement Form by fax to 1-847-236-3000.
For questions regarding this recall call 815-678-2000. |
Quantity in Commerce | 10 |
Distribution | Nationwide Distribution to AR, AZ, CA, CT, FL, GA, IL, IN, KY, LA, MI, MN, NC, NH, NV, NY, OR, PA, SC, TN, TX, VA, and WI. |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|